Antimicrobial Peptide Combination Can Hinder Resistance Evolution

Overview

Journal Microbiol Spectr

Specialty Microbiology

Date 2022 Jul 21

PMID 35862981

Authors

Bar Maron

Jens Rolff

Jonathan Friedman

Zvi Hayouka

Affiliations

Soon will be listed here.

Abstract

Antibiotic-resistant microbial pathogens are becoming a major threat to human health. Therefore, there is an urgent need to develop new alternatives to conventional antibiotics. One such promising alternative is antimicrobial peptides (AMPs), which are produced by virtually all organisms and typically inhibit bacteria via membrane disruption. However, previous studies demonstrated that bacteria can rapidly develop AMP resistance. Here, we study whether combination therapy, known to be able to inhibit the evolution of resistance to conventional antibiotics, can also hinder the evolution of AMP resistance. To do so, we evolved the opportunistic pathogen Staphylococcus aureus in the presence of individual AMPs, AMP pairs, and a combinatorial antimicrobial peptide library. Treatment with some AMP pairs indeed hindered the evolution of resistance compared with individual AMPs. In particular, resistance to pairs was delayed when resistance to the individual AMPs came at a cost of impaired bacterial growth and did not confer cross-resistance to other tested AMPs. The lowest level of resistance evolved during treatment with the combinatorial antimicrobial peptide library termed random antimicrobial peptide mixture, which contains more than a million different peptides. A better understanding of how AMP combinations affect the evolution of resistance is a crucial step in order to design "resistant proof" AMP cocktails that will offer a sustainable treatment option for antibiotic-resistant pathogens. The main insights gleaned from this study are the following. (i) AMP combination treatment can delay the evolution of resistance in S. aureus. Treatment with some AMP pairs resulted in significantly lower resistance then treatment with either of the individual AMPs. Treatment with a random AMP library resulted in no detectable resistance. (ii) The rate at which resistance to combination arises correlates with the cost of resistance to individual AMPs and their cross-resistance. In particular, combinations to which the least resistance arose involved AMPs with high fitness cost of resistance and low cross-resistance. (iii) No broad-range AMP resistance evolved. Strains that evolved resistance to some AMPs typically remained sensitive to other AMPs, alleviating concerns regarding the evolution of resistance to immune system AMPs in response to AMP treatment.

Citing Articles

Random antimicrobial peptide mixtures as non-antibiotic antimicrobial agents for cultured meat industry.

Yakir I, Cohen E, Schlesinger S, Hayouka Z Food Chem (Oxf). 2025; 10:100240.

PMID: 39927159 PMC: 11804736. DOI: 10.1016/j.fochms.2025.100240.

Antimicrobial peptide glatiramer acetate targets Pseudomonas aeruginosa lipopolysaccharides to breach membranes without altering lipopolysaccharide modification.

Murphy R, Pizzato J, Cuthbertson L, Sabnis A, Edwards A, Nolan L NPJ Antimicrob Resist. 2025; 2(1):4.

PMID: 39843948 PMC: 11702655. DOI: 10.1038/s44259-024-00022-x.

Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics.

Summer K, Guo Q, Liu L, Barkla B, Giles S, Benkendorff K PLoS One. 2025; 20(1):e0312305.

PMID: 39836702 PMC: 11750097. DOI: 10.1371/journal.pone.0312305.

Designing Analogs of SAAP-148 with Enhanced Antimicrobial and Anti-LPS Activities.

Gan L, Chi Y, Peng Y, Li S, Gao H, Zhang X Int J Mol Sci. 2024; 25(21).

PMID: 39519326 PMC: 11546786. DOI: 10.3390/ijms252111776.

Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii.

Alexander P, Oyama L, Olleik H, Godoy Santos F, OBrien S, Cookson A NPJ Biofilms Microbiomes. 2024; 10(1):92.

PMID: 39349945 PMC: 11443000. DOI: 10.1038/s41522-024-00560-2.

References

Lee G, Dallas S, Wang Y, Olsen R, Lawson K, Wilson J . Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization. J Antimicrob Chemother. 2017; 72(9):2461-2468. PMC: 5890715. DOI: 10.1093/jac/dkx200. View

Nichol D, Rutter J, Bryant C, Hujer A, Lek S, Adams M . Antibiotic collateral sensitivity is contingent on the repeatability of evolution. Nat Commun. 2019; 10(1):334. PMC: 6338734. DOI: 10.1038/s41467-018-08098-6. View

Diamond G, Beckloff N, Weinberg A, Kisich K . The roles of antimicrobial peptides in innate host defense. Curr Pharm Des. 2009; 15(21):2377-92. PMC: 2750833. DOI: 10.2174/138161209788682325. View

Bennett R, Oh M, Kuo S, Belo Y, Maron B, Malach E . Random Peptide Mixtures as Safe and Effective Antimicrobials against and MRSA in Mouse Models of Bacteremia and Pneumonia. ACS Infect Dis. 2021; 7(3):672-680. PMC: 8880176. DOI: 10.1021/acsinfecdis.0c00871. View

Topman-Rakover S, Malach E, Burdman S, Hayouka Z . Antibacterial lipo-random peptide mixtures exhibit high selectivity and synergistic interactions. Chem Commun (Camb). 2020; 56(80):12053-12056. DOI: 10.1039/d0cc04493h. View

Aubry-Damon H, Soussy C, Courvalin P . Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1998; 42(10):2590-4. PMC: 105902. DOI: 10.1128/AAC.42.10.2590. View

Conlon J, Sonnevend A, Davidson C, Smith D, Nielsen P . The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei. Biochem Biophys Res Commun. 2004; 320(1):170-5. DOI: 10.1016/j.bbrc.2004.05.141. View

Yokoyama S, Kato K, Koba A, Minami Y, Watanabe K, Yagi F . Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds. Peptides. 2008; 29(12):2110-7. DOI: 10.1016/j.peptides.2008.08.007. View

Hayouka Z, Chakraborty S, Liu R, Boersma M, Weisblum B, Gellman S . Interplay among subunit identity, subunit proportion, chain length, and stereochemistry in the activity profile of sequence-random peptide mixtures. J Am Chem Soc. 2013; 135(32):11748-51. PMC: 3856984. DOI: 10.1021/ja406231b. View

10.

Zasloff M, Martin B, Chen H . Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A. 1988; 85(3):910-3. PMC: 279666. DOI: 10.1073/pnas.85.3.910. View

11.

Konig E, Zhou M, Wang L, Chen T, Bininda-Emonds O, Shaw C . Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): implications for the evolution of frog skin defensive secretions. Toxicon. 2012; 60(6):967-81. DOI: 10.1016/j.toxicon.2012.06.015. View

12.

Aoki W, Ueda M . Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics. Pharmaceuticals (Basel). 2013; 6(8):1055-81. PMC: 3817730. DOI: 10.3390/ph6081055. View

13.

Shaw L, Aish J, Davenport J, Brown M, Lithgow J, Simmonite K . Investigations into sigmaB-modulated regulatory pathways governing extracellular virulence determinant production in Staphylococcus aureus. J Bacteriol. 2006; 188(17):6070-80. PMC: 1595368. DOI: 10.1128/JB.00551-06. View

14.

El Shazely B, Yu G, Johnston P, Rolff J . Resistance Evolution Against Antimicrobial Peptides in Alters Pharmacodynamics Beyond the MIC. Front Microbiol. 2020; 11:103. PMC: 7033599. DOI: 10.3389/fmicb.2020.00103. View

15.

Mandal S, Dey S, Mandal M, Sarkar S, Maria-Neto S, Franco O . Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water. Peptides. 2008; 30(4):633-7. DOI: 10.1016/j.peptides.2008.12.001. View

16.

Lazzaro B, Zasloff M, Rolff J . Antimicrobial peptides: Application informed by evolution. Science. 2020; 368(6490). PMC: 8097767. DOI: 10.1126/science.aau5480. View

17.

Le Loir Y, Baron F, Gautier M . Staphylococcus aureus and food poisoning. Genet Mol Res. 2003; 2(1):63-76. View

18.

Tareq F, Lee M, Lee H, Lee J, Lee Y, Shin H . Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis. Mar Drugs. 2014; 12(2):871-85. PMC: 3944520. DOI: 10.3390/md12020871. View

19.

Hayouka Z, Bella A, Stern T, Ray S, Jiang H, Grovenor C . Binary Encoding of Random Peptide Sequences for Selective and Differential Antimicrobial Mechanisms. Angew Chem Int Ed Engl. 2017; 56(28):8099-8103. DOI: 10.1002/anie.201702313. View

20.

Dobson A, Purves J, Kamysz W, Rolff J . Comparing selection on S. aureus between antimicrobial peptides and common antibiotics. PLoS One. 2013; 8(10):e76521. PMC: 3799789. DOI: 10.1371/journal.pone.0076521. View